Thus, on the basis of the pathophysiology underlying obesity, alleviation of leptin resistance is a reasonable and long-awaited therapeutic strategy for treating obesity, the anticipated outcome of which would be normalization of energy metabolism regulation. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.